Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K V Roskos

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pharmaceutical Biotechnology|January 1, 1997
Degradable controlled release systems useful for protein deliveryK V Roskos, R Maskiewicz
Drugs & Aging|September 1, 1992
Percutaneous absorption and age. Implications for therapyK V Roskos, H I Maibach
Pharmaceutical Research|November 1, 1989
Assessment of skin barrier function using transepidermal water loss: effect of ageK V Roskos, R H Guy
Clinical Materials|December 9, 1992
A morphine-triggered delivery system useful in the treatment of heroin addictionK V Roskos, J A Tefft, J Heller
Journal of Biomedical Materials Research|June 1, 1992
The effect of lipase on the release of naltrexone from triglyceride-coated cellulose acetate phthalate microspheresJ A Tefft, K V Roskos, J Heller
Biomaterials|July 1, 1990
Development of enzymatically degradable protective coatings for use in triggered drug delivery systems: derivatized starch hydrogelsJ Heller, S H Pangburn, K V Roskos
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1989
The effect of aging on percutaneous absorption in manK V Roskos, H I Maibach, R H Guy
Dermatologic Clinics|July 1, 1986
Percutaneous absorption in the agedK V Roskos, R H Guy, H I Maibach
Biomaterials|May 1, 1990
Controlled drug release from bioerodible hydrophobic ointmentsJ Heller, S Y Ng, B K Fritzinger, et al.
Journal of Biomedical Materials Research|November 1, 1995
A study of reversibly inactivated lipases for use in a morphine-triggered naltrexone delivery systemG R Nakayama, K V Roskos, B K Fritzinger, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmaceutical Biotechnology|January 1, 1997
Degradable controlled release systems useful for protein deliveryK V Roskos, R Maskiewicz
Drugs & Aging|September 1, 1992
Percutaneous absorption and age. Implications for therapyK V Roskos, H I Maibach
Pharmaceutical Research|November 1, 1989
Assessment of skin barrier function using transepidermal water loss: effect of ageK V Roskos, R H Guy
Clinical Materials|December 9, 1992
A morphine-triggered delivery system useful in the treatment of heroin addictionK V Roskos, J A Tefft, J Heller
Journal of Biomedical Materials Research|June 1, 1992
The effect of lipase on the release of naltrexone from triglyceride-coated cellulose acetate phthalate microspheresJ A Tefft, K V Roskos, J Heller
Biomaterials|July 1, 1990
Development of enzymatically degradable protective coatings for use in triggered drug delivery systems: derivatized starch hydrogelsJ Heller, S H Pangburn, K V Roskos
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1989
The effect of aging on percutaneous absorption in manK V Roskos, H I Maibach, R H Guy
Dermatologic Clinics|July 1, 1986
Percutaneous absorption in the agedK V Roskos, R H Guy, H I Maibach
Biomaterials|May 1, 1990
Controlled drug release from bioerodible hydrophobic ointmentsJ Heller, S Y Ng, B K Fritzinger, et al.
Journal of Biomedical Materials Research|November 1, 1995
A study of reversibly inactivated lipases for use in a morphine-triggered naltrexone delivery systemG R Nakayama, K V Roskos, B K Fritzinger, et al.
Pageof 2